Literature DB >> 9737862

Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1.

Y M Zheng1, M B Fisher, N Yokotani, Y Fujii-Kuriyama, A E Rettie.   

Abstract

Alignment of xenobiotic-metabolizing P450 protein sequences highlights an invariant proline residue in the meander region two amino acids N-terminal to the distal arginine of the putative ERR triad thought to be important for heme binding. This occurs as a serine in the sequences derived from human CYP4B1 gDNA and both human lung and placental CYP4B1 cDNAs. Reversion of this serine to the conserved proline residue (Ser427 --> Pro) by site-directed mutagenesis conferred the ability to incorporate heme on the human placental enzyme. Mutation of the corresponding proline in rabbit CYP4B1 (Pro422 --> Ser) abolished heme incorporation. Membrane preparations of human CYP4B1(Pro) and rabbit CYP4B1(Pro), but not the corresponding CYP4B1(Ser) variants, supported lauric acid hydroxylation preferentially at the omega-position. Purified, reconstituted human CYP4B1(Pro) and rabbit CYP4B1(Pro) formed 12-hydroxylauric acid at rates of 17-21 min-1, and both enzymes were also C-8 to C-10 fatty acid omega-hydroxylases preferentially, with total rates of hydroxylation decreasing in the order C-12 > C-10 > C-9 > C-8. Finally, neither human nor rabbit CYP4B1(Pro) formed detectable levels of any hydroxylated testosterone metabolites. Therefore, the presence of a consensus Pro-X-Arg motif is critical for incorporation of the heme prosthetic group in human and rabbit CYP4B1 proteins expressed in insect cells. Native human CYP4B1, expressed in vivo, is likely to be functionally impaired if Pro427 is required for holoenzyme expression in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737862     DOI: 10.1021/bi981280m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

Review 1.  Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.

Authors:  Thomas A Baillie; Allan E Rettie
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

2.  Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.

Authors:  Katharina Roellecke; Vera D Jäger; Veselin H Gyurov; John P Kowalski; Stephanie Mielke; Allan E Rettie; Helmut Hanenberg; Constanze Wiek; Marco Girhard
Journal:  Protein Eng Des Sel       Date:  2017-03-01       Impact factor: 1.650

Review 3.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

4.  Novel insights into oxidation of fatty acids and fatty alcohols by cytochrome P450 monooxygenase CYP4B1.

Authors:  Florian A Thesseling; Michael C Hutter; Constanze Wiek; John P Kowalski; Allan E Rettie; Marco Girhard
Journal:  Arch Biochem Biophys       Date:  2019-12-01       Impact factor: 4.013

Review 5.  Reactive metabolites in the biotransformation of molecules containing a furan ring.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2012-10-24       Impact factor: 3.739

6.  Differential gene expression in human conducting airway surface epithelia and submucosal glands.

Authors:  Anthony J Fischer; Kelli L Goss; Todd E Scheetz; Christine L Wohlford-Lenane; Jeanne M Snyder; Paul B McCray
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

7.  Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.

Authors:  Constanze Wiek; Eva M Schmidt; Katharina Roellecke; Marcel Freund; Mariko Nakano; Edward J Kelly; Wolfgang Kaisers; Vladimir Yarov-Yarovoy; Christof M Kramm; Allan E Rettie; Helmut Hanenberg
Journal:  Biochem J       Date:  2015-01-01       Impact factor: 3.857

8.  Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution.

Authors:  Eva M Schmidt; Constanze Wiek; Oliver T Parkinson; Katharina Roellecke; Marcel Freund; Michael Gombert; Nadine Lottmann; Charles A Steward; Christof M Kramm; Vladimir Yarov-Yarovoy; Allan E Rettie; Helmut Hanenberg
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

9.  Molecular dynamics of CYP2D6 polymorphisms in the absence and presence of a mechanism-based inactivator reveals changes in local flexibility and dominant substrate access channels.

Authors:  Parker W de Waal; Kyle F Sunden; Laura Lowe Furge
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.